pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
onclive·May 5·1 min read
save

Study links specific dietary fats to pancreatic cancer risk, highlighting oleic acid as promoter and omega-3s as protective

May 5, 2026·read at onclive ↗Neutral

Researchers at Yale Cancer Center examined how different types of dietary fat affect pancreatic cancer development in a mouse model. Rather than focusing on total fat intake, the study compared twelve individual fat sources under isocaloric conditions.

Mice fed a diet rich in the monounsaturated fatty acid oleic acid showed a marked increase in tumor burden, despite oleic acid’s reputation for cardiovascular benefits. This effect was most pronounced in male mice.

Conversely, diets high in polyunsaturated fatty acids, especially omega‑3 fish oil, cut pancreatic tumor development by roughly half, indicating a protective role that was observed in both sexes.

The investigators linked these outcomes to ferroptosis, a form of cell death driven by lipid oxidation. Oleic‑rich diets reduced lipid peroxidation and ferroptosis, while PUFA‑rich diets heightened oxidative stress and cell death, suggesting that the balance of MUFA to PUFA influences cancer susceptibility.

source

This writeup was produced by pharmadog from original reporting by onclive.

Original headline: “The Type of Fat—Not the Amount—Fuels Pancreatic Cancer”

read at onclive ↗
2,310 words · retrieved May 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
FATE THERAPEUTICS INC
drugs
OMEGAVEN4icosapent ethyl3Novel TherapeuticObesityzenocutuzumab
topics
Oncology63Breast Cancer8HER26NSCLC4Cardiology3Hematology3TROP-23Antibody-Drug Conjugate (ADC)2Endocrinology & Metabolism2Oncolytic Virus2Prostate Cancer2Pulmonology2Radioligand Therapy2AMDAMLBispecific AntibodyDiabetic Macular EdemaEGFRGlioblastomaImmunologyKRASMelanomaMonoclonal AntibodyNeurologyObesityPsychiatry & CNSSmall MoleculeType 2 Diabetes

related stories

  • May 12Second Clinical Scenario - Progressive Disease Despite Hematocrit Controlonclive
  • May 13How Reimagined Research Endeavors Intersect With Dignified End-of-Life Care: With D. Ross Camidge, MD, PhD; and Charles D. Blanke, MD, FACP, FASCOonclive
  • May 10Five Under 5: Top Oncology Videos for the Week of 5/3onclive
  • May 9The OncFive: Top Oncology Articles for the Week of 5/3onclive
  • May 8Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive